Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues

The Synthetic Cannabinoid Withdrawal Syndrome

(2013) Nicholas Nacca et al.   Journal of Addiction Medicine

Blood Synthetic Cannabinoid Concentrations in Cases of Suspected Impaired Driving

(2013) J. K. Yeakel et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism

(2013) Melanie Hutter et al.   JOURNAL OF MASS SPECTROMETRY

Ischemic stroke after use of the synthetic marijuana "spice"

(2013) M. J. Freeman et al.   NEUROLOGY

Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings

(2012) Maren Hermanns-Clausen et al.   ADDICTION

A Characterization of Synthetic Cannabinoid Exposures Reported to the National Poison Data System in 2010

(2012) Christopher O. Hoyte et al.   ANNALS OF EMERGENCY MEDICINE

AKI Associated with Synthetic Cannabinoids: A Case Series

(2012) G. K. Bhanushali et al.   Clinical Journal of the American Society of Nephrology

First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201

(2012) David McQuade et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Synthetic Cannabinoid Intoxication: A Case Series and Review

(2012) Carson R. Harris et al.   JOURNAL OF EMERGENCY MEDICINE

Risky Recreation: Synthetic Cannabinoids Have Dangerous Effects

(2012) Teena M. McGuinness et al.   JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES

Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2

(2011) A. Mir et al.   PEDIATRICS